TPG GP A, LLC

Insider Reports History

Location
Fort Worth, TX
Signature
/s/ Matthew White, Vice President, TPG GP A, LLC (4)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by TPG GP A, LLC:

Form 4 holding 10%+ Owner

TPG Inc.

Security class
TPG Operating Group Common Units
Shares / value
228,652,641
Estimated value
$6,711,823,893
Report date
30 Mar 2023
Price
$29.35
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Life Time Group Holdings, Inc.

Security class
Class A Common Stock
Shares / value
21,404,488
Estimated value
$628,863,857
Report date
06 Jun 2025
Price
$29.38
Ownership
Indirect
Form 4 holding Former 10% Owner

ServiceTitan, Inc.

Security class
Class A Common Stock
Shares / value
5,107,469
Estimated value
$483,421,941
Report date
13 Dec 2024
Price
$94.65
Ownership
Indirect
Form 4 holding 10%+ Owner

TPG Twin Brook Capital Income Fund

Security class
Common shares of beneficial interest, Class I
Shares / value
17,175,144
Estimated value
$432,719,156
Report date
29 Jan 2026
Price
$25.19
Ownership
Indirect
Form 4 holding 10%+ Owner

Nextracker Inc.

Security class
Class A Common Stock
Shares / value
6,044,918
Estimated value
$342,142,359
Report date
05 Feb 2024
Price
$56.60
Ownership
Indirect
Form 4 holding Former 10% Owner

Progyny, Inc.

Security class
Common Stock
Shares / value
6,350,000
Estimated value
$240,538,000
Report date
07 Aug 2023
Price
$37.88
Ownership
Indirect
Form 4 holding 10%+ Owner

Nextracker Inc.

Security class
Common Unit and Class B Common Stock
Shares / value
3,856,175
Estimated value
$136,175,807
Report date
05 Feb 2024
Price
$35.31
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Allogene Therapeutics, Inc.

Security class
Common Stock
Shares / value
18,716,306
Estimated value
$59,413,042
Report date
12 Jan 2022
Price
$3.17
Ownership
Indirect
Form 4 holding Former 10% Owner

Amneal Pharmaceuticals, Inc.

Security class
Class A Common Stock
Shares / value
12,328,767
Estimated value
$50,877,123
Report date
12 Dec 2022
Price
$4.13
Ownership
Indirect
Form 4 holding Former 10% Owner

Bicara Therapeutics Inc.

Security class
Common Stock
Shares / value
1,960,425
Estimated value
$25,962,692
Report date
16 Sep 2024
Price
$13.24
Ownership
Indirect
Form 4 holding 10%+ Owner

Ceribell, Inc.

Security class
Common Stock
Shares / value
3,967,422
Estimated value
$8,966,374
Report date
15 Oct 2024
Price
$2.26
Ownership
Indirect
Form 4 holding Former Director & 10% Owner

Nerdy Inc.

Security class
Class A Common Stock
Shares / value
8,068,206
Estimated value
$7,987,524
Report date
12 Nov 2024
Price
$0.9900
Ownership
Indirect
Form 4 holding Former 10% Owner

Trevi Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,824,883
Estimated value
$7,726,264
Report date
05 Jul 2022
Price
$2.02
Ownership
Indirect
Form 4 holding Former 10% Owner

Cushman & Wakefield plc

Security class
Ordinary Shares
Shares / value
0
Estimated value
$0
Report date
22 May 2024
Price
$11.00
Ownership
Indirect
Form 4 holding Former 10% Owner

BETA Technologies, Inc.

Security class
Class A Common Stock
Shares / value
16,395,435
Estimated value
Report date
05 Nov 2025
Price
Ownership
Indirect
Form 4 holding Former 10% Owner

BETA Technologies, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
05 Nov 2025
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

BETA Technologies, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
05 Nov 2025
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

BETA Technologies, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
05 Nov 2025
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Bicara Therapeutics Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Ceribell, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
15 Oct 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Ceribell, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
15 Oct 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner and Director

McAfee Corp.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
01 Mar 2022
Price
$26.00
Ownership
Indirect
Form 4 holding Former 10% Owner and Director

McAfee Corp.

Security class
Class A Unit and Class B Common Stock
Shares / value
0
Estimated value
Report date
01 Mar 2022
Price
$26.00
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Odyssey Therapeutics, Inc.

Security class
Series D Preferred Stock
Shares / value
0
Estimated value
Report date
11 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

Odyssey Therapeutics, Inc.

Security class
Warrants (right to buy)
Shares / value
0
Estimated value
Report date
11 May 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Former 10% Owner

ServiceTitan, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
13 Dec 2024
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Former 10% Owner

ServiceTitan, Inc.

Security class
Series H Preferred Stock
Shares / value
0
Estimated value
Report date
13 Dec 2024
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Sionna Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
10 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Sionna Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
10 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Sionna Therapeutics, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
10 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Sionna Therapeutics, Inc.

Security class
Series Seed Preferred Stock
Shares / value
0
Estimated value
Report date
10 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by TPG GP A, LLC

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .